Definition and epidemiology
Delirium tremens (DTs) is the most severe manifestation of alcohol withdrawal syndrome, defined by the presence of delirium (acute confusion with disturbed attention and awareness) plus marked autonomic hyperactivity in a patient withdrawing from alcohol.
- Occurs in roughly 5% of patients hospitalized for alcohol withdrawal; up to 50% of untreated severe withdrawal cases may progress to DTs.
- Typical onset is 48-96 hours after the last drink, though it can occasionally occur later.
- Untreated mortality has historically been cited around 5-15%, dropping substantially with modern benzodiazepine-based critical care.
- Risk is highest in patients with a long history of heavy daily alcohol use, prior episodes of DTs or withdrawal seizures, and concurrent acute illness or trauma.
- DTs typically begins 48-96 hours after last drink, later than withdrawal seizures (6-48 hours) and alcoholic hallucinosis (12-48 hours).
- Delirium (impaired attention/consciousness) plus autonomic hyperactivity distinguishes DTs from simple alcoholic hallucinosis, where insight is preserved.
- Benzodiazepines are first-line treatment; CIWA-Ar score guides symptom-triggered dosing.
- Give thiamine before/with glucose to avoid precipitating Wernicke encephalopathy.
- Pathophysiology: unmasked glutamate (NMDA) hyperactivity plus reduced GABA inhibition after chronic alcohol use.
- Antipsychotics may be used adjunctively for hallucinations/agitation but never as monotherapy — they lower seizure threshold.
- Risk factors: prior DTs or withdrawal seizures (kindling), long heavy use, concurrent acute illness.
- Untreated mortality has been historically cited up to 15%; with treatment, well under 5%.
Etiology and risk factors
DTs results from abrupt cessation or significant reduction of alcohol intake in someone who is physiologically dependent.
Risk factors
- Long duration and high quantity of alcohol use (classically years of heavy daily drinking)
- Prior episodes of alcohol withdrawal, seizures, or DTs (kindling phenomenon)
- Concurrent infection, trauma, surgery, or other acute medical illness
- Older age
- Abnormal liver function or electrolyte disturbances (hypokalemia, hypomagnesemia)
- Longer interval since last drink at presentation and higher blood alcohol level at admission
Pathophysiology
Chronic alcohol use enhances GABA-A receptor-mediated inhibition and suppresses NMDA glutamate receptor activity, producing a net neuroinhibitory tone that the brain compensates for through downregulation of GABA-A receptors and upregulation of NMDA receptors and excitatory neurotransmission.
When alcohol is abruptly withdrawn, the chronic compensatory upregulation of excitatory glutamatergic activity is unmasked, while GABAergic inhibition is simultaneously reduced. The result is a hyperexcitable, hyperadrenergic state: central nervous system irritability, autonomic surge (catecholamine excess), and risk of seizures. This same mechanism explains why benzodiazepines (GABA-A agonists) are effective treatment and why abrupt benzodiazepine withdrawal can mimic the same picture.
Clinical features
Symptoms typically evolve along a continuum, with DTs representing the most severe end.
Timeline
- 6-12 hours: tremor, anxiety, headache, mild autonomic symptoms, GI upset
- 12-48 hours: possible alcoholic hallucinosis (visual, auditory, or tactile hallucinations with insight preserved) and withdrawal seizures
- 48-96 hours: delirium tremens
Features of DTs
- Fluctuating confusion, disorientation, and impaired attention (delirium)
- Vivid visual hallucinations (classically small animals/insects) and tactile hallucinations (formication)
- Agitation and psychomotor hyperactivity
- Marked autonomic hyperactivity: tachycardia, hypertension, hyperthermia, diaphoresis, mydriasis
- Coarse tremor
- Insomnia
Unlike simple alcoholic hallucinosis, in DTs insight is lost and consciousness/attention are impaired.
Diagnosis
Diagnosis is clinical, based on history of alcohol use and withdrawal timing combined with characteristic exam findings.
- History: last drink timing, quantity/duration of use, prior withdrawal or DTs, prior seizures
- Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar) scale used to grade severity and guide treatment
- Vital signs showing autonomic instability (tachycardia, hypertension, fever)
- Labs to assess complications and rule out mimics: electrolytes (magnesium, potassium, phosphate), glucose, liver function tests, complete blood count, blood alcohol level, urine toxicology
- Consider CT head if focal neurologic signs, head trauma, or atypical presentation to exclude structural causes
- Thiamine should be given empirically given risk of coexisting Wernicke encephalopathy, which can mimic or coexist with DTs
Differential diagnosis
| Condition | Distinguishing feature |
|---|---|
| Wernicke encephalopathy | Ataxia, ophthalmoplegia, confusion; thiamine deficiency; may coexist |
| Sedative-hypnotic withdrawal (benzodiazepine, barbiturate) | Similar autonomic/delirium picture, different substance history |
| Sepsis/CNS infection | Fever, possible meningismus; blood/CSF cultures needed |
| Hepatic encephalopathy | Asterixis, elevated ammonia, history of cirrhosis |
| Hypoglycemia or electrolyte derangement | Rapid correction improves mental status |
| Serotonin syndrome/anticholinergic toxicity | Medication history, clonus, dry skin (anticholinergic) |
| Alcoholic hallucinosis | Hallucinations with preserved insight, no delirium |
Management
DTs is a medical emergency requiring inpatient, often ICU-level, monitoring and treatment.
Core therapy
- Benzodiazepines are first-line and mainstay of treatment; symptom-triggered dosing guided by CIWA-Ar is preferred over fixed-schedule dosing in appropriately monitored patients.
- Long-acting agents (diazepam, chlordiazepoxide) are often favored for smoother withdrawal course; lorazepam or oxazepam preferred in patients with significant hepatic impairment due to simpler metabolism.
- Severe, benzodiazepine-refractory agitation may require escalating doses, phenobarbital, or adjunctive agents (e.g., dexmedetomidine for autonomic symptoms, or antipsychotics for hallucinations as adjuncts only, never as monotherapy since they lower seizure threshold and do not treat withdrawal itself).
Supportive care
- Thiamine before or with glucose administration to prevent precipitating Wernicke encephalopathy
- Correction of fluid and electrolyte abnormalities (magnesium, potassium, phosphate)
- Cardiac and neurologic monitoring for arrhythmia, seizures, and aspiration risk
- Minimize sensory overstimulation; calm, well-lit environment to reduce disorientation and agitation
- Address comorbid infection, trauma, or other precipitating illness
Guideline consensus (ASAM, major US and European critical care societies) agrees on benzodiazepines as first line; specific agent choice and symptom-triggered versus fixed dosing protocols vary by institution and patient factors.
Complications and prognosis
- Seizures (can occur before or during DTs)
- Aspiration pneumonia
- Cardiac arrhythmias and cardiovascular collapse
- Severe hyperthermia and rhabdomyolysis
- Electrolyte-related complications (e.g., cardiac effects of hypomagnesemia/hypokalemia)
- Prolonged ICU stay and increased risk of hospital-acquired infections
With prompt recognition and benzodiazepine-based treatment in a monitored setting, mortality is low (well under 5%). Untreated or inadequately treated DTs carries substantially higher mortality historically cited up to 15%. Long-term prognosis depends on sustained abstinence; relapse risk is high without addiction treatment and follow-up.
DTs = "Delirium + Tachycardia (and other autonomic signs)" — remember the timeline with the rule of "6-12-24-48-96": 6-12h tremor/anxiety, 12-24h hallucinosis, 24-48h seizures, 48-96h DTs.
Practice questions
1. A 52-year-old man with a 20-year history of heavy daily alcohol use is brought to the emergency department by family after being found confused at home. He reports his last drink was 3 days ago. Vital signs show temperature 38.4°C, heart rate 128/min, blood pressure 168/98 mmHg, and diaphoresis. He is disoriented and reports seeing insects crawling on the walls, with fluctuating attention throughout the exam. Which of the following is the most appropriate initial pharmacologic treatment?
2. A 45-year-old woman with alcohol use disorder is admitted for withdrawal management. She has significant cirrhosis with elevated liver enzymes and a prolonged INR. Which benzodiazepine is preferred in this setting to minimize risk of oversedation from drug accumulation?
3. A patient undergoing treatment for delirium tremens receives intravenous dextrose for presumed hypoglycemia before thiamine is administered. Which of the following complications is this sequence most likely to precipitate?
Frequently asked questions
What causes delirium tremens?
Delirium tremens is caused by abrupt cessation or reduction of alcohol intake in someone with long-standing heavy alcohol dependence. Chronic alcohol use suppresses excitatory NMDA glutamate signaling and enhances inhibitory GABA activity; the brain compensates by upregulating excitatory pathways. When alcohol is removed, this unmasked excitatory drive combined with reduced GABA tone produces the hyperadrenergic, delirious state.
What are the first symptoms of delirium tremens?
The earliest withdrawal symptoms, appearing 6-12 hours after the last drink, are tremor, anxiety, sweating, nausea, and insomnia, not DTs itself. True delirium tremens develops later, usually 48-96 hours after the last drink, and presents with confusion, disorientation, vivid hallucinations, agitation, fever, tachycardia, and hypertension.
How is delirium tremens diagnosed?
Delirium tremens is diagnosed clinically based on a history of recent alcohol cessation in a dependent drinker combined with exam findings of delirium (fluctuating confusion, impaired attention) and autonomic hyperactivity (tachycardia, hypertension, fever, diaphoresis). The CIWA-Ar scale helps grade severity, and labs/imaging are used mainly to exclude mimics like infection, hypoglycemia, or Wernicke encephalopathy.
Is delirium tremens curable?
Delirium tremens itself is a temporary, treatable medical emergency that typically resolves within days with benzodiazepine therapy and supportive care in a monitored setting. However, it is a marker of underlying alcohol use disorder, which requires ongoing addiction treatment to prevent relapse and recurrence of future withdrawal episodes.
Delirium tremens vs alcoholic hallucinosis — what is the difference?
Alcoholic hallucinosis involves visual, auditory, or tactile hallucinations with preserved insight and normal attention, usually starting 12-48 hours after the last drink and without significant autonomic instability. Delirium tremens, in contrast, involves true delirium with impaired attention and consciousness plus marked autonomic hyperactivity, typically starting later (48-96 hours) and carrying a risk of death if untreated.
Key drugs
Related conditions and differentials
Sources and further reading
StatPearls (NCBI Bookshelf)MedlinePlusWHO ICD-10: F10.4
Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.